Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Software Analyzes Neuroimaging Data and Patient Information to Diagnose 10 Types of Dementia

By MedImaging International staff writers
Posted on 02 Sep 2024

Alzheimer’s disease is the leading cause of dementia, which broadly refers to impairments in cognitive functions such as memory and language that affect daily living. More...

However, diagnosing dementia is challenging due to the possible coexistence of multiple dementia causes, often making it difficult to identify the precise cause until it is too late for effective intervention. A new artificial intelligence (AI) tool has been developed to accurately diagnose the cause of cognitive decline, aiding doctors in establishing a more accurate diagnosis quickly.

Developed by a team of researchers from Boston University (Boston, MA, USA) and external collaborators, the AI tool utilizes a range of commonly collected patient information, including medical history, medication usage, demographic details, and results from neurological and neuropsychological exams, alongside neuroimaging data such as MRI scans. This information is processed by the AI software to predict the type of dementia and provide a confidence score. The algorithm which has been trained with data from over 50,000 individuals across nine global datasets is capable of diagnosing 10 different dementia types, such as vascular dementia and frontotemporal dementia, even when they are present simultaneously.

The effectiveness of this AI tool was evaluated by having neurologists assess 100 cases both with and without the assistance of the AI software. The results, published in Nature Medicine, demonstrated that the AI-enhanced evaluations increased diagnostic accuracy by 26%. With a global shortage of neurology specialists and a rising number of dementia patients, this discrepancy strains healthcare systems. An AI diagnostic tool could significantly alleviate the burden on healthcare professionals who are pressed for time and resources. The research team is now focused on advancing this AI tool into clinical settings for broader testing, aiming to integrate it into hospitals and practices for routine use.

“We believe AI can help by identifying these disorders early and assisting doctors in managing their patients more effectively, preventing the diseases from getting worse,” said Boston University’s Vijaya B. Kolachalama, an expert on using computers to aid medical diagnoses, who developed the AI tool.

Related Links:
Boston University


Adjustable Mobile Barrier
M-458
Post-Processing Imaging System
DynaCAD Prostate
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.